Alessandro Magrì, Global Director – AI for Precision Healthcare Oncology and Hematology at AstraZeneca shared on LinkedIn:
“Best Poster Award at ESMO AI 2026!
Proud to share that our AstraZeneca work with Collaborators at Nova In Silico ‘A Digital Twin Framework for Synthetic Control Arm Generation: A Proof-of Concept Assessment of the Phase III Trial Intervention Cohort’ has received the best poster award at ESMO AI and Digital Oncology Congress 2026 in Berlin!
We developed a white-box approach to successfully reproduce the clinical trial control arm survival data and closely predict treatment benefit with consistent results across patient subgroups.
Huge potential towards generating robust comparative evidence when randomized control arms are unavailable, potentially transforming how we design, evaluate and submit clinical trials.
Congrats to the Team: Martin Dreyling (LMU Hospital Munich), Simon A., Yishu Wang, Simon Baillet, Riad Kahoul, Claire C. (Nova in Silico) and Tristan Gonzalez, Rucha V., Holly Kimko, PhD, FAAPS (AstraZeneca).”
You may also be interested in:
Humaid Al-Shamsi: Nexomic Celebrates a Major Milestone with 50 Abstracts at ESMO AI 2026
Mieke Hemelrijck: Guy’s Cancer RWE Programme Showcased at ESMO AI 2026